23 related articles for article (PubMed ID: 8625277)
1. Vaccination against prostate cancer using a live tissue factor deficient cell line in Lobund-Wistar rats.
Heinrich JE; Pollard M; Wolter WA; Liang Z; Song H; Rosen ED; Suckow MA
Cancer Immunol Immunother; 2007 May; 56(5):725-30. PubMed ID: 16953436
[TBL] [Abstract][Full Text] [Related]
2. Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.
Kamocka M; Pollard M; Suckow M; Mielicki WP; Rosen ED
Comp Med; 2008 Jun; 58(3):282-6. PubMed ID: 18589871
[TBL] [Abstract][Full Text] [Related]
3. Rat models of bone metastases.
Blouin S; Baslé MF; Chappard D
Clin Exp Metastasis; 2005; 22(8):605-14. PubMed ID: 16670964
[TBL] [Abstract][Full Text] [Related]
4. Antitumorigenic Evaluation of Thalidomide Alone and in Combination with Cisplatin in DBA2/J Mice.
Ruddy JM; Majumdar SK
J Biomed Biotechnol; 2002; 2(1):7-13. PubMed ID: 12488594
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide in cancer treatment: a potential role in the elderly?
Zhou S; Kestell P; Tingle MD; Paxton JW
Drugs Aging; 2002; 19(2):85-100. PubMed ID: 11950376
[TBL] [Abstract][Full Text] [Related]
6. Increased growth and incidence of lymph node metastases due to the angiogenesis inhibitor AGM-1470.
Hori K; Li HC; Saito S; Sato Y
Br J Cancer; 1997; 75(12):1730-4. PubMed ID: 9192974
[TBL] [Abstract][Full Text] [Related]
7. New roles for thalidomide.
Powell RJ
BMJ; 1996 Aug; 313(7054):377-8. PubMed ID: 8761209
[No Abstract] [Full Text] [Related]
8. PA-III rat prostate adenocarcinoma cells (review).
Koutsilieris M
In Vivo; 1992; 6(2):199-203. PubMed ID: 1326342
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide promotes metastasis of prostate adenocarcinoma cells (PA-III) in L-W rats.
Pollard M
Cancer Lett; 1996 Mar; 101(1):21-4. PubMed ID: 8625277
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of metastasis of prostate adenocarcinoma cells by immune-suppressive cyclosporine A.
Pollard M
Cancer Lett; 1997 Jan; 111(1-2):221-4. PubMed ID: 9022150
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of 4-hydroxyphenyl retinamide (4-HPR) on metastasis of prostate adenocarcinoma-III cells in Lobund-Wistar rats.
Pollard M; Luckert PH
Cancer Lett; 1991 Aug; 59(2):159-63. PubMed ID: 1832081
[TBL] [Abstract][Full Text] [Related]
12. The anti-metastatic effect of intravenously-inoculated BCG on prostate tumor cells.
Pollard M; Luckert PH
Anticancer Res; 1993; 13(3):705-8. PubMed ID: 8317900
[TBL] [Abstract][Full Text] [Related]
13. Small intestinal submucosa does not promote PAIII tumor growth in Lobund-Wistar rats.
Hodde JP; Suckow MA; Wolter WR; Hiles MC
J Surg Res; 2004 Aug; 120(2):189-94. PubMed ID: 15234212
[TBL] [Abstract][Full Text] [Related]
14. Interference with in vivo growth and metastasis of prostate adenocarcinoma (PA-III) by ICRF-159.
Pollard M; Burleson GR; Luckert PH
Prostate; 1981; 2(1):1-9. PubMed ID: 7279810
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
